1. Home
  2. PERI vs IPSC Comparison

PERI vs IPSC Comparison

Compare PERI & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perion Network Ltd.

PERI

Perion Network Ltd.

HOLD

Current Price

$9.30

Market Cap

428.3M

Sector

Technology

ML Signal

HOLD

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.14

Market Cap

362.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PERI
IPSC
Founded
1999
2019
Country
Israel
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
428.3M
362.5M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
PERI
IPSC
Price
$9.30
$2.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$14.50
$4.25
AVG Volume (30 Days)
394.2K
420.6K
Earning Date
05-20-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.30
EPS
N/A
N/A
Revenue
N/A
$109,164,000.00
Revenue This Year
$9.98
N/A
Revenue Next Year
$2.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1556.76
52 Week Low
$7.63
$0.44
52 Week High
$11.27
$2.97

Technical Indicators

Market Signals
Indicator
PERI
IPSC
Relative Strength Index (RSI) 40.85 49.75
Support Level $9.20 $1.88
Resistance Level $9.70 $2.39
Average True Range (ATR) 0.27 0.10
MACD -0.06 0.01
Stochastic Oscillator 7.30 51.39

Price Performance

Historical Comparison
PERI
IPSC

About PERI Perion Network Ltd.

Perion Network Ltd is a technology company. It offers online advertising and search solutions to brands, agencies, and publishers through desktop, mobile, and social channels. It connects advertisers to consumers across digital advertising channels, including search advertising, social, display, video, digital audio, digital out of home (DOOH), and Connected TV (CTV) advertising. The company earns prime revenue from search advertising and display advertising services. It operates in the business segment of High Impact Advertising solutions. Geographically, the company generates a majority of its revenue from the United States and the rest from other regions.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

Share on Social Networks: